Literature DB >> 22310709

Hypertension: Does antihypertensive treatment have long-term benefits?

Giuseppe Mancia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22310709     DOI： 10.1038/nrcardio.2012.11

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Antihypertensives in octogenarians.

Authors:  Giuseppe Mancia
Journal:  BMJ       Date:  2012-01-04

2.  Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial.

Authors:  N Beckett; R Peters; J Tuomilehto; C Swift; P Sever; J Potter; T McCormack; F Forette; B Gil-Extremera; D Dumitrascu; J A Staessen; L Thijs; A Fletcher; C Bulpitt
Journal:  BMJ       Date:  2011-01-04

3.  Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.

Authors: 
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

4.  Association between chlorthalidone treatment of systolic hypertension and long-term survival.

Authors:  John B Kostis; Javier Cabrera; Jerry Q Cheng; Nora M Cosgrove; Yingzi Deng; Sara L Pressel; Barry R Davis
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.

Authors:  Jackie Bosch; Eva Lonn; Janice Pogue; J Malcolm O Arnold; Gilles R Dagenais; Salim Yusuf
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

7.  Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990.

Authors:  P A Sytkowski; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

8.  Extent of cardiovascular risk reduction associated with treatment of isolated systolic hypertension.

Authors:  Kim Sutton-Tyrrell; Rachel Wildman; Anne Newman; Lewis H Kuller
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

9.  Long-term follow-up after tight control of blood pressure in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; H Andrew W Neil; David R Matthews
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

10.  Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.

Authors:  Jan A Staessen; Lutgarde Thijisq; Robert Fagard; Hilde Celis; Willem H Birkenhäger; Christopher J Bulpitt; Peter W de Leeuw; Astrid E Fletcher; François Forette; Gastone Leonetti; Patricia McCormack; Choudomir Nachev; Eoin O'Brien; José L Rodicio; Joseph Rosenfeld; Cinzia Sarti; Jaakko Tuomilehto; John Webster; Yair Yodfat; Alberto Zanchetti
Journal:  J Hypertens       Date:  2004-04       Impact factor: 4.844
  10 in total
  1 in total

1.  Use of single pill combinations in the treatment of arterial hypertension in Poland: The current practice and guidelines, the impact on reimbursement spending and patient co-payment.

Authors:  Marcin Czech; Stefan Boguslawski; Anna Smaga; Krzysztof J Filipiak
Journal:  Cardiol J       Date:  2022-05-17       Impact factor: 3.487
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.